During the autumn, RaySearch has reorganized its Development Department to adapt the structure to the large expansion in the number of employees involved in development in recent years. As part of this reorganization, the previous Product Director Anders Murman has taken over as Director of Development and, consequently, assumed full responsibility for the daily development work. The former Director of Development Anders Liander will focus on more forward-looking development matters.
The management of the Finance Department will also change. The current CFO Ola Enarson will leave RaySearch to assume the position of CFO at Mantacore AB. He will be replaced by the current Director of Marketing Anders Martin-Löf, who will assume the CFO position in January 2009.
”The reorganization does not imply any major changes in our operations. We had almost outgrown the old structure in the Development Department so we have now have put a more distinct and effective organization in place. Both Anders Murman and Anders Martin-Löf are already members of the Executive Management Team and are fully familiar with the company so we retain continuity in operations. I would also like to take this opportunity to thank Ola Enarson, who has been responsible for building up the finance function at RaySearch since our introduction on the stock exchange in 2003,” says Johan Löf, President of RaySearch.
ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners such as Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have been released to date and RaySearch’s software is used at over 1,300 clinics in more than 30 countries. In addition, existing license agreements cover more than 15 other products that are scheduled to be launched in the coming years. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the SmallCap segment on the OMX Nordic Exchange Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com.
Press releases
